Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 654
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Int J Neuropsychopharmacol ; 27(5)2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38695786

RESUMEN

BACKGROUND: Major depressive disorder (MDD) is commonly treated with selective serotonin reuptake inhibitors (SSRIs). SSRIs inhibit the serotonin transporter (5-HTT), but the downstream antidepressant mechanism of action of these drugs is poorly understood. The serotonin 1B (5-HT1B) receptor is functionally linked to 5-HTT and 5-HT1B receptor binding and 5-HT1B receptor mRNA is reduced in the raphe nuclei after SSRI administration in primates and rodents, respectively. The effect of SSRI treatment on 5-HT1B receptor binding in patients with MDD has not been examined previously. This positron emission tomography (PET) study aimed to quantify brain 5-HT1B receptor binding changes in vivo after SSRI treatment for MDD in relation to treatment effect. METHODS: Eight unmedicated patients with moderate to severe MDD underwent PET with the 5-HT1B receptor radioligand [11C]AZ10419369 before and after 3 to 4 weeks of treatment with the SSRI escitalopram 10 mg daily. Depression severity was assessed at time of PET and after 6 to 7 weeks of treatment with the Montgomery-Åsberg Depression Rating Scale. RESULTS: We observed a significant reduction in [11C]AZ10419369 binding in a dorsal brainstem (DBS) region containing the median and dorsal raphe nuclei after escitalopram treatment (P = .036). Change in DBS [11C]AZ10419369 binding correlated with Montgomery-Åsberg Depression Rating Scale reduction after 3-4 (r = 0.78, P = .021) and 6-7 (r = 0.94, P < .001) weeks' treatment. CONCLUSIONS: Our findings align with the previously reported reduction of 5-HT1B receptor binding in the raphe nuclei after SSRI administration and support future studies testing change in DBS 5-HT1B receptor binding as an SSRI treatment response marker.


Asunto(s)
Trastorno Depresivo Mayor , Escitalopram , Tomografía de Emisión de Positrones , Receptor de Serotonina 5-HT1B , Inhibidores Selectivos de la Recaptación de Serotonina , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Benzopiranos , Encéfalo/metabolismo , Encéfalo/diagnóstico por imagen , Encéfalo/efectos de los fármacos , Citalopram/farmacología , Trastorno Depresivo Mayor/tratamiento farmacológico , Trastorno Depresivo Mayor/metabolismo , Trastorno Depresivo Mayor/diagnóstico por imagen , Escitalopram/metabolismo , Escitalopram/farmacología , Escitalopram/uso terapéutico , Morfolinas , Piperazinas/farmacología , Unión Proteica/efectos de los fármacos , Receptor de Serotonina 5-HT1B/metabolismo , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Resultado del Tratamiento
2.
J Intern Med ; 286(3): 309-316, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31108016

RESUMEN

Since the establishment of the Seldinger technique for secure entry to the vascular system, there has been a rapid evolution in imaging and catheters that has made the arteries and veins internal routes to any place in the body for interventions. It is curious that a general exit from the vasculature in a similar manner has not been proposed earlier. Possibly, the simplest reason is that accidental perforation of the vasculature by guide wire or catheter is a feared adverse event in endovascular intervention. Most places in the body can be reached by ultrasonography or computed tomography-guided intervention. Some organs such as the central nervous system, the heart and pancreas are harder to access and, in some organs, like the kidney, repeated percutaneous punctions to cover large areas is not suitable. We present a new general purpose micro-endovascular device creating a working channel to these 'hard to reach' organs by an inverted Seldinger technique. This review details this trans-vessel wall technique, which has been studied in pancreas for transplantation of insulin-producing cells, for injection of contrast agent to the heart and to the brain, bowels and kidney in rat, rabbit, swine and macaque monkeys with up to one year of follow-up without adverse events. Furthermore, the payloads that can be given through such a system are briefly discussed. Drugs, cells, gene vectors and other therapeutic substances may be injected directly to the tissue to increase efficacy and decrease risk of off-site adverse effects.


Asunto(s)
Procedimientos Endovasculares/instrumentación , Células Secretoras de Insulina/trasplante , Trasplante de Órganos/métodos , Animales , Vasos Sanguíneos , Diseño de Equipo , Humanos , Macaca , Conejos , Instrumentos Quirúrgicos , Porcinos
3.
J Intern Med ; 285(4): 398-406, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30289186

RESUMEN

OBJECTIVES: With the emergence of targeted cell transplantation and gene therapy, there is a need for minimally invasive tissue access to facilitate delivery of therapeutic substrate. The objective of this study was to demonstrate the suitability of an endovascular device which is able to directly access tissue and deliver therapeutic agent to the heart, kidney and pancreas without need to seal the penetration site. METHODS: In vivo experiments were performed in 30 swine, including subgroups with follow-up to evaluate complications. The previously described trans-vessel wall (VW) device was modified to be sharper and not require tip detachment to seal the VW. Injections into targets in the heart (n = 13, 24-h follow-up n = 5, 72-h follow-up n = 3), kidney (n = 8, 14-day follow-up n = 3) and pancreas (n = 5) were performed. Some animals were used for multiple organ injections. Follow-up consisted of clinical monitoring, angiography and necropsy. Transvenous (in heart) and transarterial approaches (in heart, kidney and pancreas) were used. Injections were targeted towards the subepicardium, endomyocardium, pancreas head and tail, and kidney subcapsular space and cortex. RESULTS: Injections were successful in target organs, visualized by intraparenchymal contrast on fluoroscopy and by necropsy. No serious complications (defined as heart failure or persistent arrhythmia, haemorrhage requiring treatment or acute kidney injury) were encountered over a total of 157 injections. CONCLUSIONS: The trans-VW device can achieve superselective injections to the heart, pancreas and kidney for delivery of therapeutic substances without tip detachment. All parts of these organs including the subepicardium, pancreas tail and renal subcapsular space can be efficiently reached.


Asunto(s)
Trasplante de Células/métodos , Sistemas de Liberación de Medicamentos/métodos , Procedimientos Endovasculares/métodos , Corazón , Riñón , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Páncreas , Animales , Estudios de Factibilidad , Inyecciones/métodos , Porcinos
4.
Acta Psychiatr Scand ; 140(3): 196-204, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31334829

RESUMEN

OBJECTIVE: Electroconvulsive therapy (ECT) is used in patients with severe forms of bipolar depression. ECT is effective but not all patients respond. The aim of this study was to determine prognostic factors for response to ECT in patients hospitalized for bipolar depression. METHODS: Data were obtained from several national Swedish registers. All patients with bipolar depression treated with ECT in any hospital in Sweden between 2011 and 2016 for whom information about ECT response was available were included (n = 1251). Response was defined as a score on the Clinical Global Impression - Improvement scale of one or two. Univariate and multivariate logistic regression were conducted to investigate associations between socio-demographic and clinical factors and response. RESULTS: Response was achieved in 80.2% patients. Older age was associated with higher response rate to ECT. Patients with comorbid obsessive-compulsive disorder or personality disorder, and patients previously treated with lamotrigine had lower response rate. CONCLUSION: Electroconvulsive therapy for bipolar depression was associated with very high response rates. The strongest prognostic factors were higher age, absence of comorbid obsessive-compulsive disorder or personality disorder, and less prior pharmacologic treatment.


Asunto(s)
Trastorno Bipolar/terapia , Terapia Electroconvulsiva , Evaluación de Resultado en la Atención de Salud , Sistema de Registros , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Suecia , Adulto Joven
5.
J Intern Med ; 279(4): 315-36, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26522443

RESUMEN

Nitric oxide (NO) is generated endogenously by NO synthases to regulate a number of physiological processes including cardiovascular and metabolic functions. A decrease in the production and bioavailability of NO is a hallmark of many major chronic diseases including hypertension, ischaemia-reperfusion injury, atherosclerosis and diabetes. This NO deficiency is mainly caused by dysfunctional NO synthases and increased scavenging of NO by the formation of reactive oxygen species. Inorganic nitrate and nitrite are emerging as substrates for in vivo NO synthase-independent formation of NO bioactivity. These anions are oxidation products of endogenous NO generation and are also present in the diet, with green leafy vegetables having a high nitrate content. The effects of nitrate and nitrite are diverse and include vasodilatation, improved endothelial function, enhanced mitochondrial efficiency and reduced generation of reactive oxygen species. Administration of nitrate or nitrite in animal models of cardiovascular disease shows promising results, and clinical trials are currently ongoing to investigate the therapeutic potential of nitrate and nitrite in hypertension, pulmonary hypertension, peripheral artery disease and myocardial infarction. In addition, the nutritional aspects of the nitrate-nitrite-NO pathway are interesting as diets suggested to protect against cardiovascular disease, such as the Mediterranean diet, are especially high in nitrate. Here, we discuss the potential therapeutic opportunities for nitrate and nitrite in prevention and treatment of cardiovascular and metabolic diseases.


Asunto(s)
Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Metabólicas/tratamiento farmacológico , Nitratos/uso terapéutico , Nitritos/uso terapéutico , Animales , Disponibilidad Biológica , Presión Sanguínea/efectos de los fármacos , Enfermedades Cardiovasculares/prevención & control , Sistema Cardiovascular/efectos de los fármacos , Modelos Animales de Enfermedad , Insuficiencia Cardíaca/tratamiento farmacológico , Humanos , Hipertensión Pulmonar/tratamiento farmacológico , Leucocitos/efectos de los fármacos , Enfermedades Metabólicas/prevención & control , Infarto del Miocardio/tratamiento farmacológico , Infarto del Miocardio/metabolismo , Nitratos/metabolismo , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/biosíntesis , Nitritos/metabolismo , Activación Plaquetaria/efectos de los fármacos , Daño por Reperfusión/tratamiento farmacológico , Vasodilatación/efectos de los fármacos
6.
Int J Clin Pract ; 70(4): 319-29, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26997295

RESUMEN

BACKGROUND: Hyponatraemia (HN; serum sodium level < 135 mmol/l) is the most common electrolyte disturbance seen in clinical practice, and is associated with varying spectrum of symptoms. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most common aetiology in hospitalised patients, and can be caused by several different underlying conditions. AIMS: The objectives of this study were to retrospectively examine the baseline characteristics, clinical outcomes and hospital resource utilisation of patients with HN and/or SIADH in Sweden over a 10-year period from 2001 to 2011. Additional analysis was performed on subpopulations of patients with hip fracture, pneumonia and small cell lung cancer (SCLC) to see if trends in outcomes were consistent across a broad range of aetiologies commonly associated with the condition. METHODS: Patient information was taken from the Swedish National Patient Registry, the Swedish Cancer Registry, the Swedish Cause of Death Register and the Swedish Prescribed Drug Register. A total of 34,537 patients (4.38%) were identified with HN and/or SIADH, with the incidence and prevalence rising over the 10-year study period. RESULTS: Of the 34,537 patients identified, 841 had hip fracture, 2635 had pneumonia and 106 had SCLC. Compared with matched control patients, those with HN and/or SIADH had a longer length of hospital stay, a higher re-admission rate and a shorter time to re-admission. CONCLUSIONS: This study showed that HN and/or SIADH negatively impact patient outcomes and healthcare resources related to hospital stay irrespective of the underlying cause. The impact of HN is not confined to the initial hospitalisation, as re-admission rates are also affected.


Asunto(s)
Costo de Enfermedad , Predicción , Hiponatremia/economía , Vigilancia de la Población/métodos , Sistema de Registros , Adolescente , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Humanos , Hiponatremia/epidemiología , Incidencia , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Distribución por Sexo , Suecia/epidemiología , Adulto Joven
7.
Am J Transplant ; 14(3): 694-700, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24517268

RESUMEN

Insulin-producing cells are transplanted by portal vein injection as an alternative to pancreas transplantation in both clinical and preclinical trials. Two of the main limitations of portal vein transplantation are the prompt activation of the innate immunity and concomitant loss of islets and a small but significant risk of portal vein thrombosis. Furthermore, to mimic physiological release, the insulin-producing cells should instead be located in the pancreas. The trans-vessel wall approach is an endovascular method for penetrating the vessel wall from the inside. In essence, a working channel is established to the parenchyma of organs that are difficult to access by percutaneous technique. In this experiment, we accessed the extra-vascular pancreatic parenchyma in swine by microendovascular technique and injected methylene blue, contrast fluids and insulin-producing cells without acute adverse events. Further, we evaluated the procedure itself by a 1-year angiographical follow-up, without adverse events. This study shows that the novel approach utilizing endovascular minimal invasiveness coupled to accurate trans-vessel wall placement of an injection in the pancreatic parenchyma with insulin-producing cells is possible. In clinical practice, the potential benefits compared to portal vein cell transplantation should significantly improve endocrine function of the graft and potentially reduce adverse events.


Asunto(s)
Procedimientos Endovasculares/métodos , Supervivencia de Injerto/fisiología , Insulina/metabolismo , Trasplante de Islotes Pancreáticos , Islotes Pancreáticos/citología , Páncreas/cirugía , Angiografía , Animales , Glucemia/análisis , Péptido C/metabolismo , Técnicas para Inmunoenzimas , Secreción de Insulina , Páncreas/diagnóstico por imagen , Páncreas/patología , Porcinos
8.
Nitric Oxide ; 38: 45-57, 2014 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-24650698

RESUMEN

The discovery of nitric oxide and its role in almost every facet of human biology opened a new avenue for treatment through manipulation of its canonical signaling and by attempts to augment endogenous nitric oxide generation through provision of substrate and co-factors to the endothelial nitric oxide synthase complex. This has been particularly so in the cardiovascular system and it is well recognized that there is reduced bioavailable nitric oxide in patients with both cardiovascular risk factors and manifest vascular disease. However, these attempts have failed to deliver the expected benefits of such an approach. Recently, an alternative pathway for nitric oxide synthesis has been elucidated that can produce authentic nitric oxide from the 1 electron reduction of inorganic nitrite. Furthermore, it has long been known that symbiotic, facultative, oral microflora can facilitate the reduction of inorganic nitrate, that is ingested in the average diet in millimolar amounts, to inorganic nitrite itself. Thus, there exists an alternative reductive pathway from nitrate, via nitrite as an intermediate, to nitric oxide that provides a novel pathway that may be amenable to therapeutic manipulation. As such, various research groups have explored the utility of manipulation of this nitrate-nitrite-nitric oxide pathway in situations in which nitric oxide is known to have a prominent role. Animal and early-phase human studies of both inorganic nitrite and nitrate supplementation have shown beneficial effects in blood pressure control, platelet function, vascular health and exercise capacity. This review considers in detail the pathways of inorganic nitrate bioactivation and the evidence of clinical utility to date on the cardiovascular system.


Asunto(s)
Sistema Cardiovascular/metabolismo , Salud , Nitratos/metabolismo , Animales , Enfermedades Cardiovasculares/dietoterapia , Enfermedades Cardiovasculares/metabolismo , Humanos , Nitratos/administración & dosificación
9.
J Intern Med ; 274(3): 227-32, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23844970

RESUMEN

OBJECTIVE: Findings from animal studies indicate that growth hormone (GH) may stimulate the production of the putative metabolic regulator fibroblast growth factor 21 (FGF21). We investigated whether circulating FGF21 levels are altered in patients with GH deficiency and characterized how levels of this growth factor are influenced by acute and long-term administration of GH, and the potential relationship between FGF21 and nonesterified fatty acids (NEFAs). DESIGN AND SETTING: GH-deficient patients (n = 9) were studied prior to and during 1 year of replacement with GH. Healthy subjects (n = 8) received an intravenous bolus of GH with or without concomitant oral glucose. Healthy subjects and patients with heterozygous familial hypercholesterolaemia (n = 23) were monitored following increasing doses of GH for 3 weeks. The main outcome measures were serum FGF21 and NEFA levels. Studies were performed at two academic centres. RESULTS: GH-deficient patients had FGF21 levels within the normal range, and GH replacement did not influence circulating FGF21 or NEFA concentrations. Acute GH administration to healthy control subjects did not change FGF21 levels, whereas an oral glucose load increased serum FGF21 by 25% and reduced NEFA levels by 48%. Similar effects were seen on administration of glucose together with GH. However, FGF21 levels increased dose dependently up to 3.7-fold in control subjects treated with GH for 3 weeks; simultaneously NEFA levels were increased by 47%. CONCLUSIONS: GH is not critical for the maintenance of basal serum FGF21 levels in humans, but circulating FGF21 levels increase following administration of GH to healthy individuals. There is no correlation between plasma NEFA and circulating FGF21 levels.


Asunto(s)
Ácidos Grasos no Esterificados/sangre , Factores de Crecimiento de Fibroblastos/sangre , Hormona de Crecimiento Humana/uso terapéutico , Análisis de Varianza , Estudios de Casos y Controles , Ensayo de Inmunoadsorción Enzimática , Femenino , Hormona de Crecimiento Humana/deficiencia , Humanos , Hiperlipoproteinemia Tipo II/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Nefelometría y Turbidimetría , Radioinmunoensayo
10.
Dis Esophagus ; 26(8): 853-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22882570

RESUMEN

One-lung ventilation (OLV) is applied during esophagectomy to improve exposure during the thoracic part of the operation. Collapse of lung tissue, shunting of pulmonary blood flow, and changes in alveolar oxygenation during and after OLV may possibly induce an ischemia-reperfusion response in the lung, which may affect the pulmonary endothelium. Such a reaction might thereby contribute to the frequently occurring respiratory complications among these patients. In this small trial, 30 patients were randomized to either OLV (n= 16) or two-lung ventilation (TLV, n= 14) during esophagectomy. Central venous and arterial plasma samples were taken before and after OLV/TLV for analysis of nitrite and a metabolite of nitric oxide (NO), and also during the 1st, 2nd, 3rd, and 10th postoperative day for analysis of endothelin, another endothelium-derived vasoactive mediator. Lung biopsies were taken before and after OLV or TLV, and analyzed regarding immunofluorescence for isoform of NO synthase, a protein upregulated during inflammatory response and also vascular congestion. No changes in lung isoform of NO synthase immunofluorescence or vascular congestion were registered after neither OLV nor TLV. Plasma nitrite and endothelin levels were similar in the two study groups. We conclude that OLV does not seem to have any influence on key regulators of pulmonary vascular tone and inflammation, i.e. NO and endothelin. From this perspective, OLV seems to be a safe method, which defends its clinical position to facilitate surgical exposure during thoracoabdominal esophagectomy.


Asunto(s)
Endotelina-1/metabolismo , Esofagectomía/métodos , Lesión Pulmonar/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Óxido Nítrico/metabolismo , Ventilación Unipulmonar/métodos , Daño por Reperfusión/metabolismo , Adenocarcinoma/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Biomarcadores/metabolismo , Carcinoma de Células Escamosas/cirugía , Estudios de Cohortes , Neoplasias Esofágicas/cirugía , Carcinoma de Células Escamosas de Esófago , Femenino , Humanos , Pulmón/irrigación sanguínea , Pulmón/metabolismo , Lesión Pulmonar/etiología , Masculino , Persona de Mediana Edad , Ventilación Unipulmonar/efectos adversos , Daño por Reperfusión/etiología , Respiración Artificial/métodos
11.
Transl Psychiatry ; 12(1): 226, 2022 06 02.
Artículo en Inglés | MEDLINE | ID: mdl-35654778

RESUMEN

Objective measures, such as activity monitoring, can potentially complement clinical assessment for psychiatric patients. Alterations in rest-activity patterns are commonly encountered in patients with major depressive disorder. The aim of this study was to investigate whether features of activity patterns correlate with severity of depression symptoms (evaluated by Montgomery-Åsberg Rating Scale (MADRS) for depression). We used actigraphy recordings collected during ongoing major depressive episodes from patients not undergoing any antidepressant treatment. The recordings were acquired from two independent studies using different actigraphy systems. Data was quality-controlled and pre-processed for feature extraction following uniform procedures. We trained multiple regression models to predict MADRS score from features of activity patterns using brute-force and semi-supervised machine learning algorithms. The models were filtered based on the precision and the accuracy of fitting on training dataset before undergoing external validation on an independent dataset. The features enriched in the models surviving external validation point to high depressive symptom severity being associated with less complex activity patterns and stronger coupling to external circadian entrainers. Our results bring proof-of-concept evidence that activity patterns correlate with severity of depressive symptoms and suggest that actigraphy recordings may be a useful tool for individual evaluation of patients with major depressive disorder.


Asunto(s)
Trastorno Depresivo Mayor , Antidepresivos/uso terapéutico , Trastorno Depresivo Mayor/tratamiento farmacológico , Humanos , Escalas de Valoración Psiquiátrica
12.
Am J Physiol Gastrointest Liver Physiol ; 300(2): G327-33, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21109593

RESUMEN

The colonic mucus layer serves as an important barrier and prevents colonic bacteria from invading the mucosa and cause inflammation. The regulation of colonic mucus secretion is poorly understood. The aim of this study was to investigate the role of the mucus barrier in induction of colitis. Furthermore, regulation of mucus secretion by luminal bacterial products was studied. The colon of anesthetized Muc2(-/-), Muc1(-/-), wild-type (wt), and germ-free mice was exteriorized, the mucosal surface was visualized, and mucus thickness was measured with micropipettes. Colitis was induced by DSS (dextran sodium sulfate, 3%, in drinking water), and disease activity index (DAI) was assessed daily. The colonic mucosa of germ-free and conventionally housed mice was exposed to the bacterial products LPS (lipopolysaccharide) and PGN (peptidoglycan). After DSS induction of colitis, the thickness of the firmly adherent mucus layer was significantly thinner after 5 days and onward, which paralleled the increment of DAI. Muc2(-/-) mice, which lacked firmly adherent mucus, were predisposed to colitis, whereas Muc1(-/-) mice were protected with significantly lower DAI by DSS compared with wt mice. The mucus barrier increased in Muc1(-/-) mice in response to DSS, whereas significantly fewer T cells were recruited to the inflamed colon. Mice housed under germ-free conditions had an extremely thin adherent colonic mucus layer, but when exposed to bacterial products (PGN or LPS) the thickness of the adherent mucus layer was quickly restored to levels observed in conventionally housed mice. This study demonstrates a correlation between decreasing mucus barrier and increasing clinical symptoms during onset of colitis. Mice lacking colonic mucus (Muc2(-/-)) were hypersensitive to DSS-induced colitis, whereas Muc1(-/-) were protected, probably through the ability to increase the mucus barrier but also by decreased T cell recruitment to the afflicted site. Furthermore, the ability of bacteria to regulate the thickness of the colonic mucus was demonstrated.


Asunto(s)
Colitis/fisiopatología , Colon/metabolismo , Mucosa Intestinal/metabolismo , Mucina-1/metabolismo , Mucina 2/metabolismo , Animales , Traslocación Bacteriana , Colitis/inducido químicamente , Colitis/microbiología , Colitis/patología , Colon/efectos de los fármacos , Sulfato de Dextran , Susceptibilidad a Enfermedades , Regulación hacia Abajo , Vida Libre de Gérmenes , Mucosa Intestinal/efectos de los fármacos , Lipopolisacáridos/farmacología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mucina-1/genética , Mucina 2/genética , Peptidoglicano/farmacología , Índice de Severidad de la Enfermedad , Linfocitos T/patología
13.
Nat Med ; 1(4): 370-3, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7585069

RESUMEN

Nitric oxide (NO) is present in air derived from the nasal airways. However, the precise origin and physiological role of airway-derived NO are unknown. We report that NO in humans is produced by epithelial cells in the paranasal sinuses and is present in sinus air in very high concentrations, close to the highest permissible atmospheric pollution levels. In immunohistochemical and mRNA in situ hybridization studies we show that an NO synthase most closely resembling the inducible isoform is constitutively expressed apically in sinus epithelium. In contrast, only weak NO synthase activity was found in the epithelium of the nasal cavity. Our findings, together with the well-known bacteriostatic effects of NO, suggest a role for NO in the maintenance of sterility in the human paranasal sinuses.


Asunto(s)
Óxido Nítrico/biosíntesis , Senos Paranasales/metabolismo , Adolescente , Adulto , Anciano , Anticuerpos Monoclonales , Arginina/administración & dosificación , Arginina/análogos & derivados , Biopsia , Niño , Preescolar , Inhibidores Enzimáticos/administración & dosificación , Epitelio/metabolismo , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Hibridación in Situ , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , NG-Nitroarginina Metil Éster , Mucosa Nasal/metabolismo , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Enfermedades de los Senos Paranasales/metabolismo , Fragmentos de Péptidos , ARN Mensajero/metabolismo , Respiración
14.
Acta Anaesthesiol Scand ; 59(3): 271-3, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25678227
15.
Redox Biol ; 28: 101387, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31765889

RESUMEN

Emerging evidence indicates that dietary nitrate can reverse several features of the metabolic syndrome, but the underlying molecular mechanisms still remain elusive. The aim of the present study was to explore mechanisms involved in the effects of dietary nitrate on the metabolic dysfunctions induced by high-fat diet (HFD) in mice. Four weeks old C57BL/6 male mice, exposed to HFD for ten weeks, were characterised by increased body weight, fat content, increased fasting glucose and impaired glucose clearance. All these metabolic abnormalities were significantly attenuated by dietary nitrate. Mechanistically, subcutaneous primary mouse adipocytes exposed to palmitate (PA) and treated with nitrite exhibited higher mitochondrial respiration, increased protein expression of total mitochondrial complexes and elevated gene expression of the thermogenesis gene UCP-1, as well as of the creatine transporter SLC6A8. Finally, dietary nitrate increased the expression of anti-inflammatory markers in visceral fat, plasma and bone marrow-derived macrophages (Arginase-1, Egr-2, IL-10), which was associated with reduction of NADPH oxidase-derived superoxide production in macrophages. In conclusion, dietary nitrate may have therapeutic utility against obesity and associated metabolic complications possibly by increasing adipocyte mitochondrial respiration and by dampening inflammation and oxidative stress.


Asunto(s)
Dieta Alta en Grasa/efectos adversos , Mitocondrias/metabolismo , Nitratos/administración & dosificación , Obesidad/dietoterapia , Adipocitos/citología , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Animales , Glucemia/efectos de los fármacos , Respiración de la Célula/efectos de los fármacos , Modelos Animales de Enfermedad , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , Proteínas de Transporte de Membrana/metabolismo , Ratones Endogámicos C57BL , Mitocondrias/efectos de los fármacos , Nitratos/farmacología , Obesidad/inducido químicamente , Obesidad/metabolismo , Ácido Palmítico/efectos adversos , Distribución Aleatoria , Proteína Desacopladora 1/metabolismo , Regulación hacia Arriba
16.
Science ; 234(4773): 208-9, 1986 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-17746480

RESUMEN

Fossil fishes from the Miocene La Venta fauna of the Magdalena River Valley, Colombia, are identified as Colossoma macropomum (Characidae), a living species from the Orinoco and Amazon basins. The fossils document a long and conservative history for a species that is highly specialized for feeding on streamside plants. The phylogenetically advanced position of Colossoma in the subfamily Serrasalminae implies that six related genera and other higher characid taxa originated well before 15 million years ago. This discovery also corroborates neontological evidence for a vicariance event that contributed species from Miocene Orinoco-Amazon faunas to the original Magdalena region fauna. The fossils suggest a formerly diverse Magdalena fauna that has suffered local extinction, perhaps associated with late Cenozoic tectonism. This new evidence may help explain the depauperate nature of the modern Magdalena River.

17.
Science ; 237(4810): 81-3, 1987 Jul 03.
Artículo en Inglés | MEDLINE | ID: mdl-17813624

RESUMEN

Deep-water sampling of the Orinoco River main channel resulted in the collection of an unexpectedly high abundance and diversity of specialized fishes. Twenty-eight of the more than 60 species collected belong to the Gymnotiformes(New World electric or knife fishes). One of the more numerous of these, a recently described species of the genus Rhabdolichops, consumes large numbers of very small planktonic Crustacea and insect larvae. These items are captured in the very swift, turbid, and deep waters of the Orinoco. Although the strong dependence of the river food web on terrestrial and floodplain food sources is well known, the specialized capabilities of Rhabdolichops and of other fishes that occur with it indicate a significant extension of the river food web into the main channel.

19.
J Hazard Mater ; 371: 1-7, 2019 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-30844645

RESUMEN

Li-ion batteries are used in electronic devices and electric cars, yet they create safety concerns due to the possibility of the release of combustible materials. The electrolyte, one of the main components in a Li-ion cell, consists of organic carbonates. Venting and thermal runaway release organic carbonates and when mixed with air, it can result in fires and explosions. A 20-liter explosion sphere was used to determine the explosion characteristics for three typical carbonates used in electrolytes, at 373 K, and 100 kPa absolute pressure. The explosion pressure and the maximum rate of explosion pressure rise are presented for the carbonates and for hydrogen, methane, and propane, and the explosive limits for the carbonates are also identified at the same conditions. This allowed a comparison of the explosion characteristics for the carbonates with those for hydrogen, methane, and propane. Theoretical calculations gave a higher explosion pressure than that from the experimental results most likely due to losses in the hydrocarbon experiments. The carbonates analyzed have very similar explosion pressures and rate of explosion pressure rise as propane. The explosion characteristics found for the three carbonates can be used in future consequence and risk assessments for Li-ion battery installations.

20.
Eur J Clin Invest ; 38(3): 197-200, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18257783

RESUMEN

BACKGROUND: Exhaled nitric oxide (NO) measurement is a simple and non-invasive method for monitoring airway inflammation. Similarly, nasal NO has been proposed as a surrogate marker in inflammatory diseases of the upper airways, e.g. allergic rhinitis. A new portable analyser using an electrochemical sensor has been developed for measurements of exhaled NO, and its reproducibility and comparison with other analysers has been tested recently in healthy subjects and in patients with lower airways disease. The application of this hand-held analyser in nasal NO analysis was tested and compared to the gold standard represented by a chemiluminescence analyser. MATERIALS AND METHODS: Thirty subjects including 15 patients with allergic rhinitis (AR) and 15 healthy subjects (HS) were studied. The intraindividual variability, calculated as the difference in nasal NO levels between two measurements from a single nasally exhaled breath manoeuvre, and the comparison between the electrochemical analyser (NIOX MINO, Aerocrine) and a chemiluminescence analyser (NOA, Sievers) were performed. RESULTS: In AR patients mean nasal NO was 59.0 +/- 16.3 p.p.b. with the MINO and 58.3 +/- 15.6 p.p.b. with the NOA. In HS nasal NO was 49.1 +/- 10.8 p.p.b. with the MINO and 49.8 +/- 8.2 p.p.b. with the NOA. The Bland-Altman analysis showed bias values of 0.005 +/- 3.6 with the 95% limits of agreement from -6.97 to 6.98 p.p.b. CONCLUSION: Measurements of nasal NO levels with a hand-held electrochemical analyser are reproducible and the results are comparable to a stationary chemiluminescence analyser.


Asunto(s)
Pruebas Respiratorias/instrumentación , Óxido Nítrico/análisis , Rinitis Alérgica Estacional/fisiopatología , Adulto , Pruebas Respiratorias/métodos , Electroquímica/instrumentación , Espiración , Femenino , Humanos , Luminiscencia , Masculino , Reproducibilidad de los Resultados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA